REPRESENTING THE PROFESSION THAT IMPACTS INDIVIDUAL LIVES AND COMMUNITIES
With
Michelle Oliver,
Chief Occupational Therapist
Occupational Therapy Australia
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Adelaide | November 2025
Michelle Oliver is a highly experienced Occupational Therapist with nearly two decades of leadership and clinical expertise across the mental health, homelessness, and disability sectors. She holds a Master of Occupational Therapy from the University of South Australia and is a registered practitioner with AHPRA.
As the Chief Occupational Therapist at Occupational Therapy Australia (OTA), she leads national strategies to advance clinical excellence, drive workforce development, and champion sector-wide advocacy. Her leadership is crucial in shaping OTA’s influence within the health and disability systems.
Prior to her current role, Michelle served as the Principal Occupational Therapist at the Northern Adelaide Local Health Network, gaining a deep understanding of complex care environments. She is a recipient of a SA Health award for her commitment to consumer, carer, and community participation, and is a public advocate for evidence-based practice and high-quality care.
Source: Supplied
-
New bar for cosmetic plastic surgeon accreditation
The newly established Australian and New Zealand Board of Cosmetic Plastic Surgery (ANZBCPS) has highlighted a concerning lack of confidence among cosmetic surgery patients in selecting qualified surgeons based on available online information.
In response to these challenges, the ANZBCPS has introduced the Board Certified Program to ensure patients have access to trustworthy information about qualified surgeons. Participating surgeons may use the title “ANZBCPS Board Certified,” indicating they meet stringent quality and safety standards, and adhere to the continuing professional development (CPD) requirements set by AHPRA.
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
-
Artificial Intelligence (AI) in clinical trials and clinical care
Australian Health Journal today continues a major episode release on Technology Aided Healthcare Delivery, with part 2 on Artificial Intelligence in trials and clinical care. Interviews were captured at AI, Machine Learning & Robotics in Health conference in October organised by Informa Australia.
